BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3097166)

  • 1. Evaluation of praziquantel efficiency in the treatment of schistosomiasis.
    Khalil HM; el-Hawey AM; Abdel Baki MH; el-Hadi HM; Sharara MO
    J Egypt Soc Parasitol; 1986 Dec; 16(2):403-12. PubMed ID: 3097166
    [No Abstract]   [Full Text] [Related]  

  • 2. Praziquantel in treatment of S. mansoni and S. haematobium infections.
    Ahmed TH; Ali AA; Bassiouni GA; Omer SH; Shalaby MA
    J Egypt Soc Parasitol; 1988 Jun; 18(1):313-24. PubMed ID: 3131447
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness and tolerance of praziquantel in schistosomiasis].
    Groning E; Bakathir H; Salem A; Albert L; Fernández R
    Rev Cubana Med Trop; 1985; 37(2):215-9. PubMed ID: 3938555
    [No Abstract]   [Full Text] [Related]  

  • 4. The efficacy of praziquantel in Egyptian schistosomiasis.
    Ismail MM; Bruce JI; Attia MM; el-Ridi AM; Shabayek HA; Salama MM
    J Egypt Soc Parasitol; 1986 Jun; 16(1):259-67. PubMed ID: 3088142
    [No Abstract]   [Full Text] [Related]  

  • 5. Dosage trial of a combination of oxamniquine and praziquantel in the treatment of schistosomiasis in Zimbabwean schoolchildren.
    Creasey AM; Taylor P; Thomas JE
    Cent Afr J Med; 1986 Jul; 32(7):165-7. PubMed ID: 3107836
    [No Abstract]   [Full Text] [Related]  

  • 6. The status of schistosomiasis before and after treatment among school pupils in a village in the Nile Delta, Egypt.
    Ismail MM; Bruce JI; Attia M; Husein MH; Sabah AA; Tayel SE
    J Egypt Soc Parasitol; 1988 Jun; 18(1):287-96. PubMed ID: 3131446
    [No Abstract]   [Full Text] [Related]  

  • 7. Enzyme linked immunosorbent assay for the evaluation of praziquantel therapy in different groups of bilharzial patients.
    Ismail MM; Ata AA; el-Raziky EH; el-Ridi AM; Attia MM; el-Gamal RL; el-Khashab M
    J Egypt Soc Parasitol; 1986 Jun; 16(1):269-76. PubMed ID: 3088143
    [No Abstract]   [Full Text] [Related]  

  • 8. Blood picture and liver function tests before and after praziquantel therapy of Egyptian bilharzial patients.
    Ata AA; el-Raziky EH; el-Ridi AM; Ismail MM; Attia MM; el-Gamal RL; el-Khashab M
    J Egypt Soc Parasitol; 1986 Jun; 16(1):277-85. PubMed ID: 3088144
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effectiveness of praziquantel as an antihelmintic agent in the treatment of bilharziasis].
    Doehring E; Ehrich JH
    Monatsschr Kinderheilkd; 1986 May; 134(5):282-4. PubMed ID: 3088435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic management of schistosomiasis as an imported disease in The Netherlands].
    Stuiver PC; Smith SJ; Polderman AM
    Ned Tijdschr Geneeskd; 1989 Jan; 133(4):153-4. PubMed ID: 2493591
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the efficacy and side effects of various regimens of praziquantel for the treatment of schistosomiasis.
    el Masry NA; Bassily S; Farid Z
    Trans R Soc Trop Med Hyg; 1988; 82(5):719-20. PubMed ID: 3150878
    [No Abstract]   [Full Text] [Related]  

  • 12. [Kinetics of the antibody level in schistosomiasis under chemotherapy].
    Schlisio W; Ziegler K
    Z Gesamte Inn Med; 1986 Aug; 41(15):422-7. PubMed ID: 3094264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seasonality as a determinant of the efficacy of praziquantel in population-based chemotherapy: lessons from the practice.
    Abu-Elyazeed RR; Mansour NS; Youssef FG; Boghdadi AM; el Khoby TA; Hassanein YA; el Gamal RR
    J Egypt Soc Parasitol; 1998 Apr; 28(1):1-7. PubMed ID: 9617037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of circulating schistosome antigens in serum and urine of schistosomiasis patients and assessment of cure by a monoclonal antibody.
    Demerdash ZA; Mohamed SH; Shaker ZA; Hassan SI; el Attar GM; Din AH; Abadeer NI; Mansour MM
    J Egypt Soc Parasitol; 1995 Aug; 25(2):471-84. PubMed ID: 7665943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Schistosomiasis at Marselisborg hospital 1981-1990].
    Tarp BD; Andersen PL
    Ugeskr Laeger; 1996 Feb; 158(7):911-4. PubMed ID: 8638328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Schistosoma mansoni and Schistosoma haematobium infection.
    Mahmood A; Yasir M
    J Coll Physicians Surg Pak; 2005 Jul; 15(7):443-4. PubMed ID: 16197880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schistosomiasis prevalence after administration of praziquantel to school children in Melela village, Morogoro region, Tanzania.
    Kitange HM; Swai AB; McLarty DG; Alberti KG
    East Afr Med J; 1993 Dec; 70(12):782-6. PubMed ID: 8026352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency of focal molluscicide treatment against schistosomiasis reinfection in an irrigation scheme and in a small dams area in Mali. Preliminary communication.
    Werler C
    Trop Med Parasitol; 1989 Jun; 40(2):234-6. PubMed ID: 2505385
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of praziquantel treatment of schistosomiasis in a non-endemic country: a follow-up of parasitological, clinical and immunological parameters.
    Giboda M; Loudová J; Shonová O; Boucková E; Horácek J; Numrich P; Ruppel A; Vítovec J; Lukes S; Noll P
    J Hyg Epidemiol Microbiol Immunol; 1992; 36(4):346-55. PubMed ID: 1300350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reinfection with Schistosoma haematobium and mansoni despite repeated praziquantel office treatment in Niger, Mali].
    Dabo A; Doucoure B; Koita O; Diallo M; Kouriba B; Klinkert MQ; Doumbia S; Doumbo O
    Med Trop (Mars); 2000; 60(4):351-5. PubMed ID: 11436587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.